Clinical Trial Update: Integrated Imaging Strategy to Phenotype Progression of Liver Tumors During and After Chemoembolization [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating an integrated imaging strategy to phenotype progression of liver tumors during and after chemoembolization.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma
• Liver Cancer

Snippet

Sponsor: National Institutes of Health Clinical Center (CC) | Conditions: Liver Cancer, Liver Neoplasm | Phase 2 | Status: COMPLETED | Results posted: 2019-04-23